H.C. Wainwright raised the firm’s price target on Ocular Therapeutix (OCUL) to $15 from $14 and keeps a Buy rating on the shares ...
H.C. Wainwright raised the firm’s price target on Perpetua Resources (PPTA) to $22 from $13.25 and keeps a Buy rating on the shares ...